{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T21:43:21Z","timestamp":1753739001824,"version":"3.40.5"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Medicine and Surgery"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.amsu.2018.11.013","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T11:19:58Z","timestamp":1542885598000},"page":"38-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Secondary amyloidosis associated with heroin use and recurrent infections \u2013 A case report"],"prefix":"10.1097","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2070-8984","authenticated-orcid":false,"given":"Deepthi","family":"Mani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"6","key":"10.1016\/j.amsu.2018.11.013_bib1","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/ajt.14905","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016","volume":"18","author":"Seth","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.amsu.2018.11.013_bib2","first-page":"719","article-title":"Vital signs: demographic and substance use trends among heroin users\u2014United States, 2002\u20132013","volume":"64","author":"Jones","year":"2015"},{"issue":"23","key":"10.1016\/j.amsu.2018.11.013_bib3","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.amsu.2018.11.013_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/CLEP.S39981","article-title":"Systemic AA amyloidosis: epidemiology, diagnosis, and management","volume":"6","author":"de As\u00faa","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.amsu.2018.11.013_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/add.14257","article-title":"Drawing attention to a neglected injecting\u2010related harm: a systematic review of AA amyloidosis among people who inject drugs","author":"Harris","year":"2018","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.amsu.2018.11.013_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13506129.2017.1342235","article-title":"Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre","volume":"24","author":"Lane","year":"2017","journal-title":"Amyloid"},{"issue":"4","key":"10.1016\/j.amsu.2018.11.013_bib7","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/nep.12616","article-title":"Characteristics of AA amyloidosis patients in san Francisco","volume":"21","author":"Lejmi","year":"2016","journal-title":"Nephrology"},{"key":"10.1016\/j.amsu.2018.11.013_bib8","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.13641217","article-title":"Heroin use is associated with AA-type kidney amyloidosis in the pacific northwest","author":"Sharma","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.amsu.2018.11.013_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5414\/CNP72224","article-title":"Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failure","volume":"72","author":"Manner","year":"2009","journal-title":"Clin. Nephrol."},{"issue":"1","key":"10.1016\/j.amsu.2018.11.013_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1471-2369-13-151","article-title":"Renal AA-amyloidosis in intravenous drug users\u2013a role for HIV-infection?","volume":"13","author":"Jung","year":"2012","journal-title":"BMC Nephrol."},{"issue":"4","key":"10.1016\/j.amsu.2018.11.013_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2018.06.004","article-title":"Secondary, AA, amyloidosis","volume":"44","author":"Papa","year":"2018","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"12","key":"10.1016\/j.amsu.2018.11.013_bib12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","article-title":"Therapeutic clearance of amyloid by antibodies to serum amyloid P component","volume":"373","author":"Richards","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Annals of Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080118302620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2049080118302620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T16:07:25Z","timestamp":1677082045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2049080118302620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":12,"alternative-id":["S2049080118302620"],"URL":"https:\/\/doi.org\/10.1016\/j.amsu.2018.11.013","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"print","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary amyloidosis associated with heroin use and recurrent infections \u2013 A case report","name":"articletitle","label":"Article Title"},{"value":"Annals of Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amsu.2018.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}]}}